Author Archives: Global Meds

For many patients diagnosed with locally advanced lung cancer, surgery may no longer appear possible when a tumor has invaded major blood vessels, bronchi, or other critical structures.

However, advances in multidisciplinary cancer treatment are creating new possibilities for carefully selected patients.

In 2018, a 52-year-old patient, referred to as Mr. Wang to protect his privacy, was diagnosed with advanced lung cancer during a routine medical examination. The diagnosis came unexpectedly at a time when he was managing two factories and enjoying a stable family life in Shenzhen.

Eight years after undergoing a complex procedure known as autologous lung transplantation, his latest imaging results showed no definitive evidence of tumor recurrence or metastasis.

A Tumor Involving Critical Pulmonary Structures

Further examinations showed that Mr. Wang had squamous cell carcinoma in the upper lobe of his left lung.

The tumor had already invaded or closely involved several important structures, including:

• The left main pulmonary artery
• The left main bronchus
• The left pulmonary vein
• Structures around the pulmonary hilum

Under these circumstances, conventional lung cancer surgery carried significant risks. Removing the entire affected area could have resulted in the loss of too much functioning lung tissue, while incomplete removal might not have achieved adequate tumor control.

The medical team therefore organized a multidisciplinary consultation involving specialists from cardiothoracic surgery, oncology, medical imaging, anesthesiology, respiratory and critical care medicine, pathology, and nuclear medicine.

Neoadjuvant Therapy Created an Opportunity for Surgery

After reviewing the patient’s condition, the multidisciplinary team decided to begin with two cycles of neoadjuvant chemotherapy.

Neoadjuvant therapy refers to treatment given before surgery. Its purpose is often to reduce the size or extent of a tumor, control the disease, and potentially create better conditions for surgical removal.

Following two treatment cycles, Mr. Wang’s tumor decreased in size and the disease was partially controlled.

This response provided a possible window for surgery. Nevertheless, the tumor remained closely connected to the major vessels and bronchi at the pulmonary hilum. A conventional resection still could not easily achieve both complete tumor removal and preservation of adequate lung function.

The surgical team therefore considered a highly specialized alternative: autologous lung transplantation for advanced lung cancer.

What Is Autologous Lung Transplantation?

Autologous lung transplantation is fundamentally different from a conventional donor lung transplant.

The procedure uses the patient’s own lung rather than a donor organ. During surgery, the affected lung is removed from the body. Surgeons then perform precise tumor resection and reconstruction outside the body before reimplanting the remaining healthy lung tissue.

The process may include:

1. Removing the affected lung.
2. Excising the tumor-bearing lobe and involved tissue.
3. Reconstructing the remaining bronchial and vascular structures.
4. Reimplanting the preserved healthy lung tissue.
5. Reconnecting the pulmonary vessels and bronchus.

This technique may allow surgeons to remove tumors that are difficult to treat through conventional resection while preserving more functional lung tissue.

However, it is an extremely demanding operation. It requires advanced thoracic surgical skills, precise vascular and bronchial reconstruction, experienced anesthesiology support, and close perioperative critical care.

Surgery Was Only One Part of the Treatment

Mr. Wang successfully completed the operation after detailed preoperative planning and close cooperation among several medical departments.

However, surgery alone was not considered sufficient.

After the procedure, he continued to receive comprehensive treatment, including chemotherapy and immunotherapy. He remained in stable condition for approximately three years.

In 2021, the disease recurred. The medical team administered additional chemotherapy, and the tumor was brought under control again.

This part of the case is important because it demonstrates that long-term cancer management may involve several treatment stages. Even after major surgery, patients generally require regular follow-up examinations and may need additional systemic treatment depending on their individual condition.

Eight Years Later: Imaging Consistent With Complete Remission

After several years without contact, Mr. Wang recently returned to the Department of Cardiothoracic Surgery at Southern Medical University Shenzhen Hospital for follow-up.

The medical team was encouraged to see him in good general condition eight years after the original diagnosis and operation.

Whole-body imaging showed:

• No definitive hypermetabolic tumor lesions
• No clear signs of recurrence
• No identified distant metastasis
• Lymph node findings consistent with post-treatment changes

According to the case report, these imaging findings were consistent with a highly satisfactory recovery status and complete tumor remission.

What Can Patients Learn From This Case?

Mr. Wang’s experience does not mean that autologous lung transplantation is suitable for every person with advanced lung cancer.

Eligibility depends on many factors, including:

• The precise location and extent of the tumor
• Whether distant metastasis is present
• The response to preoperative systemic therapy
• Remaining lung function
• Cardiovascular health
• The patient’s overall physical condition
• The experience of the surgical and multidisciplinary teams

Nevertheless, this case demonstrates that some patients initially considered unsuitable for conventional surgery may still have treatment opportunities after a comprehensive multidisciplinary evaluation.

For complex lung cancer cases, obtaining a second opinion from an experienced thoracic oncology team may help patients understand whether surgery, chemotherapy, immunotherapy, radiotherapy, targeted therapy, or a combined treatment strategy could be considered.

Seeking Advanced Lung Cancer Treatment in China?

Patients considering lung cancer treatment in China may benefit from having their medical records reviewed before traveling.

Our international medical coordination team can assist with:

• Medical record collection and translation
• Remote specialist consultation
• Multidisciplinary case review
• Hospital and physician matching
• Treatment appointment coordination
• Visa and travel guidance
• Interpretation during medical visits
• Follow-up communication after treatment

Every patient’s condition is different. Treatment recommendations should only be made after specialists review pathology reports, imaging examinations, previous treatment records, and the patient’s current health status.

Contact us to request a preliminary medical evaluation and learn more about advanced lung cancer treatment options in China.

For many patients, a diagnosis of advanced lung cancer can feel like the end of the road. However, advances in systemic therapy, complex thoracic surgery and multidisciplinary cancer care are creating new possibilities for carefully selected patients.

A patient treated at Southern Medical University Shenzhen Hospital provides a remarkable example. Eight years after being diagnosed with locally advanced lung cancer, he returned to the hospital in good condition, with follow-up imaging showing no definite signs of recurrence or metastasis.

A Diagnosis That Changed Everything

In May 2018, a 52-year-old patient, referred to here as Mr. Wang, underwent a routine medical examination during a visit to his hometown. A chest CT scan revealed advanced lung cancer.

Further imaging and pathological examinations confirmed squamous cell carcinoma in the upper lobe of his left lung. The tumor had already invaded several critical structures, including the left main pulmonary artery, left main bronchus and left pulmonary vein.

Because the tumor was closely connected to the major blood vessels and airways at the pulmonary hilum, conventional surgical removal carried extremely high risks. Radiotherapy and chemotherapy alone were also unlikely to provide sufficient local control.

Multidisciplinary Treatment Created a Surgical Opportunity

The hospital organized a multidisciplinary team consultation involving specialists from cardiothoracic surgery, oncology, medical imaging, anesthesiology, respiratory and critical care medicine, pathology and nuclear medicine.

Although the cancer was locally advanced, the team believed that treatment might still be possible if systemic therapy could first reduce the size of the tumor.

Mr. Wang therefore received two cycles of neoadjuvant chemotherapy. After treatment, the tumor became smaller and the disease was partially controlled, creating a potential opportunity for surgery.

However, the tumor remained closely attached to the major pulmonary vessels and bronchi. A conventional operation could not completely remove the cancer while preserving enough functioning lung tissue.

The medical team needed a different approach.

What Is Autologous Lung Transplantation?

After extensive evaluation, the cardiothoracic surgery team decided to perform an autologous lung transplantation.

Unlike conventional lung transplantation, this procedure does not involve receiving a lung from a donor. Instead, the patient’s own lung is temporarily removed from the body.

The surgical team then:

1. Removes the tumor-bearing portion of the lung outside the body.
2. Resects the affected bronchi and blood vessels.
3. Reconstructs the remaining healthy lung tissue.
4. Reconnects the bronchial and vascular structures.
5. Reimplants the reconstructed lung into the patient.

This approach can make it possible to remove tumors involving complex structures while preserving more healthy lung tissue than a complete pneumonectomy.

However, autologous lung transplantation is an exceptionally demanding procedure. It requires advanced surgical expertise, precise reconstruction of pulmonary vessels and bronchi, experienced anesthesia management and close cooperation between multiple medical departments.

Surgery Was Only One Part of the Treatment

The operation was successfully completed following detailed preoperative planning and close multidisciplinary cooperation.

After surgery, Mr. Wang continued to receive chemotherapy and immunotherapy as part of a comprehensive treatment plan. He remained in stable condition for approximately three years.

In 2021, the cancer recurred. Fortunately, further chemotherapy brought the disease under control again. The hospital later lost contact with him, and the medical team did not know how his condition had developed.

An Unexpected Return Eight Years Later

Recently, Mr. Wang returned to the Department of Cardiothoracic Surgery for a follow-up examination.

Eight years after the original diagnosis and major operation, he appeared in good health. Whole-body imaging showed no definite hypermetabolic lesions and no clear evidence of recurrent or metastatic disease. The imaging findings were considered consistent with complete remission.

His experience demonstrates that even some patients with extremely advanced disease may achieve long-term survival when appropriate systemic treatment, complex surgery and long-term follow-up are successfully combined.

What This Case Means for International Patients

This case does not mean that autologous lung transplantation is suitable for every patient with advanced lung cancer. Treatment decisions depend on many factors, including:

• Tumor location and pathological type
• Involvement of major blood vessels and bronchi
• Response to chemotherapy or immunotherapy
• Remaining lung function
• General physical condition
• Presence of distant metastases
• Surgical experience of the medical team

For international patients considering advanced lung cancer treatment in China, obtaining a multidisciplinary medical review is an important first step. Specialists can assess whether conventional surgery, systemic therapy, radiotherapy, immunotherapy or a more complex surgical strategy may be appropriate.

Hope Through Individualized Cancer Treatment

Advanced lung cancer remains a serious and challenging disease. Nevertheless, this eight-year survival story shows that an initially inoperable or extremely difficult tumor does not always mean that all treatment possibilities have been exhausted.

Through neoadjuvant chemotherapy, autologous lung transplantation, postoperative systemic treatment and continued disease management, Mr. Wang achieved an outcome that once seemed impossible.

Every patient’s condition is different, but careful evaluation and individualized treatment may reveal possibilities that are not apparent at the time of diagnosis.

CTA

Seeking advanced lung cancer treatment in China?

Our international patient coordination team can assist with medical record preparation, specialist consultations, hospital communication, translation and treatment arrangements in China.

Contact us to request an initial medical case review.

Pulmonary arterial hypertension, often called PAH, is a serious condition that affects the blood vessels between the heart and lungs. When pressure in the pulmonary arteries becomes abnormally high, the right side of the heart has to work harder to pump blood to the lungs. Over time, this may lead to worsening shortness of breath, fatigue, reduced exercise capacity, and even right heart failure.

For patients and families, PAH can be difficult to recognize in the early stage because its symptoms may look similar to ordinary tiredness, poor recovery after illness, or general heart and lung discomfort. Some patients may experience breathlessness after light activity, difficulty climbing stairs, chest discomfort, dizziness, swelling, or bluish lips caused by low oxygen levels.

In Ningbo, Zhejiang Province, Ningbo Medical Center Lihuili Hospital has built a specialized clinical team focusing on pulmonary arterial pressure abnormalities and pulmonary arterial hypertension. On March 4, 2025, Zhejiang Province announced the first batch of selected “Small but Strong” Clinical Innovation Teams. The Pulmonary Arterial Pressure Abnormality Team of Ningbo Medical Center Lihuili Hospital was the only team in Ningbo to be included in this list.

This recognition highlights the hospital’s long-term work in the diagnosis, treatment, research, and patient management of pulmonary arterial hypertension.

A Multidisciplinary Team for Complex PAH Care

Pulmonary arterial hypertension is not only a lung disease. It often requires close cooperation between different medical specialties because the condition may involve the heart, lungs, immune system, blood vessels, and long-term medication management.

The PAH team at Ningbo Medical Center Lihuili Hospital brings together specialists from several departments, including respiratory and critical care medicine, cardiology, thoracic surgery, interventional radiology, rheumatology and immunology, pharmacy, laboratory medicine, and medical-engineering innovation research.

This multidisciplinary model is especially important for patients whose PAH is related to connective tissue diseases, such as systemic lupus erythematosus, also known as SLE. In these cases, doctors need to manage both the underlying immune disease and the elevated pulmonary artery pressure.

A Patient Story: From Severe Symptoms to Long-Term Management

One patient, referred to as Ms. Hu, began experiencing progressive fatigue and shortness of breath after giving birth. At first, she believed her symptoms were related to poor postpartum recovery. However, rest did not improve her condition. Her breathlessness became worse, she could no longer climb stairs easily, and even simple activities such as going out to buy groceries became difficult.

Her lips also began to appear slightly purple, a possible sign of low oxygen levels.

After medical examinations, Ms. Hu was diagnosed with severe pulmonary arterial hypertension associated with systemic lupus erythematosus and connective tissue disease. This diagnosis meant that her immune disease and pulmonary vascular disease both needed careful management.

At Ningbo Medical Center Lihuili Hospital, a multidisciplinary team led by Dr. Wu Shibo from the Department of Respiratory and Critical Care Medicine worked together with specialists from cardiovascular medicine and rheumatology and immunology. The treatment strategy focused on two key goals: controlling lupus activity and keeping pulmonary arterial hypertension at a lower-risk level.

The team used a combined approach, including medication to control immune activity and targeted therapy to help reduce pulmonary artery pressure. Over time, Ms. Hu’s condition gradually stabilized.

During the following five years, she continued regular follow-up visits and underwent periodic right heart catheterization assessments to monitor pulmonary artery pressure. Based on her test results and clinical condition, the medical team adjusted her treatment plan when needed. Today, Ms. Hu has returned to work and resumed a more normal daily life.

Her case shows the importance of early recognition, specialist evaluation, long-term follow-up, and coordinated care for patients with pulmonary arterial hypertension.

Why Early Diagnosis Matters

PAH can progress quietly. In the beginning, symptoms such as fatigue, shortness of breath, and reduced exercise tolerance may be ignored or mistaken for other health problems. However, untreated or poorly controlled pulmonary arterial hypertension can place increasing pressure on the right side of the heart.

Patients should seek medical evaluation if they experience persistent or worsening symptoms such as:

• Shortness of breath during daily activity
• Fatigue that does not improve with rest
• Difficulty climbing stairs
• Dizziness or fainting
• Chest discomfort
• Swelling in the legs, ankles, or abdomen
• Bluish lips or skin

These symptoms do not always mean a patient has PAH, but they should not be ignored, especially if they continue or become worse.

Specialized PAH Services at Ningbo Medical Center Lihuili Hospital

According to the hospital’s clinical team, Ningbo Medical Center Lihuili Hospital has developed strong capabilities in pulmonary vascular disease care. The hospital’s PAH team has built a foundation in clinical diagnosis, targeted treatment, patient follow-up, and scientific research.

The team is also working to improve PAH screening, optimize diagnosis and treatment workflows, and explore the use of artificial intelligence to support earlier detection and better patient management.

For patients with complex PAH, especially those with immune-related conditions, multidisciplinary care can help doctors evaluate the disease more comprehensively and design a more individualized treatment plan.

Support for International Patients

For international patients considering medical care in China, pulmonary arterial hypertension treatment requires careful preparation. Patients should prepare previous medical records, imaging reports, echocardiography results, right heart catheterization reports if available, medication history, and any diagnosis related to autoimmune or connective tissue disease.

A coordinated medical service platform can help overseas patients communicate with hospitals, organize medical documents, arrange specialist consultations, and understand the treatment process before traveling.

Pulmonary arterial hypertension is a serious but manageable condition when patients receive timely diagnosis, appropriate treatment, and long-term follow-up. Ningbo Medical Center Lihuili Hospital’s specialized PAH team provides a strong example of how multidisciplinary care can support patients with complex heart, lung, and vascular disease.

Medical Disclaimer: This article is for general health information only and should not replace professional medical advice, diagnosis, or treatment. Patients with suspected pulmonary arterial hypertension should consult qualified medical professionals.

As global demand for healthy aging, preventive care and non-surgical rejuvenation continues to grow, more international patients are exploring anti-aging and regenerative medicine options in China. These services may include physician-led health assessment, skin rejuvenation, body contouring, cellular therapy consultation, and long-term wellness planning.

At GlobalMedPool, we help international patients connect with trusted medical institutions in China, prepare medical documents, arrange specialist consultations and coordinate the patient journey from initial inquiry to follow-up care.

This article introduces several major anti-aging and regenerative medicine options that patients often ask about: exosome therapy, autologous stem cell infusions, PRP facial rejuvenation, Thermage FLX and HIFEM technology.

What Is Anti-Aging & Regenerative Medicine?

Anti-aging and regenerative medicine focuses on supporting healthy aging, improving appearance-related concerns, and helping patients understand their overall biological condition through medical evaluation. Unlike ordinary beauty services, medical anti-aging should be guided by qualified physicians and based on each patient’s age, medical history, skin condition, metabolic status and treatment goals.

For international patients, a responsible anti-aging plan should begin with medical consultation rather than direct treatment. This is especially important for patients with chronic diseases, autoimmune conditions, cancer history, blood disorders, pregnancy, implanted devices or previous cosmetic procedures.

Why Choose China for Anti-Aging and Regenerative Care?

China has developed strong hospital networks, advanced medical equipment and multidisciplinary clinical resources in major cities such as Hangzhou, Ningbo, Shanghai, Guangzhou and Beijing. Some hospitals and medical groups combine general medicine, dermatology, plastic surgery, health management, rehabilitation and laboratory testing within one coordinated system.

For example, Shulan Hospital in Hangzhou is known as a large private general hospital with international medical positioning, while Ningbo Medical Center Lihuili Hospital is a major Grade III public hospital in Zhejiang with broad clinical specialties. For overseas patients, these hospital resources can support not only aesthetic treatment, but also pre-treatment screening, chronic disease evaluation and follow-up planning.

GlobalMedPool works as a medical coordination platform. Our role is not to replace doctors, but to help patients match with appropriate hospitals, understand treatment options, translate medical records, arrange appointments and coordinate communication before, during and after care.

Exosome Therapy: A Popular but Carefully Evaluated Field

Exosome therapy has become one of the most discussed topics in regenerative medicine and aesthetic wellness. Exosomes are tiny extracellular vesicles involved in cell-to-cell communication. In aesthetic settings, they are often discussed for skin repair, post-laser recovery, hair and scalp care, and general rejuvenation.

However, patients should understand that exosome-based treatments are still an evolving field. Regulations, product quality, clinical evidence and treatment protocols vary by country and institution. Patients should avoid any clinic that promises guaranteed anti-aging effects, disease cures or dramatic results without medical evaluation.

Before considering exosome-related services, patients should ask:

• What is the source of the exosome product?
• Is it used topically, with microneedling, or by injection?
• Is the product approved or permitted under local medical regulations?
• What evidence supports the intended use?
• What are the possible risks, side effects and alternatives?
• Who is responsible for follow-up if complications occur?

A responsible provider should explain both the potential benefits and the limitations clearly.

Autologous Stem Cell Infusions: Personalized but Not for Everyone

Autologous stem cell therapy refers to the use of a patient’s own cells, usually collected from blood, bone marrow or adipose tissue, depending on the clinical protocol. In anti-aging and regenerative medicine, some patients ask about autologous stem cell infusions for vitality, immune support, tissue repair or general wellness.

This area requires strict medical judgment. Stem cell procedures should never be presented as a simple beauty treatment. They involve biological materials, collection procedures, processing standards, sterility control, eligibility assessment and follow-up monitoring.

Patients should be especially cautious if they see marketing claims suggesting that stem cell infusions can reverse aging, cure chronic disease, prevent cancer, treat neurological disease or replace standard medical care. These claims may not be supported by strong clinical evidence.

For international patients, the first step should be a physician consultation and medical record review. Doctors may need to assess blood test results, immune status, infection risk, medication history and previous diagnoses before deciding whether a regenerative medicine consultation is appropriate.

PRP Facial Rejuvenation: Using the Patient’s Own Platelets

PRP, or platelet-rich plasma, is a treatment that uses a concentrated portion of the patient’s own blood. A small amount of blood is drawn, processed in a centrifuge and then applied or injected into the treatment area. In dermatology and aesthetic medicine, PRP is commonly discussed for skin texture, fine lines, acne scars, hair loss and post-procedure recovery.

PRP facial rejuvenation is often attractive to patients who prefer a more natural approach because it uses material from their own body. It may be combined with microneedling, laser treatments or other skin rejuvenation procedures depending on the doctor’s assessment.

Common goals of PRP facial rejuvenation may include:

• Improving skin texture
• Supporting collagen-related skin repair
• Reducing the appearance of fine line
• Helping acne scar appearance
• Supporting overall skin brightness and recovery

Still, PRP is not a magic solution. Results vary between patients, and multiple sessions may be needed. Patients with blood disorders, active infections, certain autoimmune conditions or unrealistic expectations may not be suitable candidates.

Thermage FLX: Non-Surgical Radiofrequency Skin Tightening

Thermage FLX is a non-invasive radiofrequency treatment designed to help smooth, tighten and contour the skin. It delivers radiofrequency energy into deeper skin layers to stimulate collagen remodeling. Many patients choose Thermage FLX because it does not require surgery or injections and usually involves little to no downtime.

Thermage FLX may be considered for patients with mild to moderate skin laxity on areas such as the face, eyelids, jawline, neck, arms, abdomen or thighs. Results are usually gradual because collagen remodeling takes time. Some patients may notice early tightening, while more visible improvement may develop over the following months.

Patients should understand that Thermage FLX is not a facelift and cannot produce the same result as surgery. It is better suited for patients looking for subtle, natural-looking tightening rather than dramatic structural change.

A proper consultation should include skin assessment, medical history review and discussion of contraindications. Patients with pacemakers, defibrillators or certain electrical implants may not be suitable for radiofrequency-based treatment.

HIFEM Technology: Muscle Stimulation and Body Contouring

HIFEM stands for High-Intensity Focused Electromagnetic technology. It uses electromagnetic energy to trigger strong muscle contractions that are difficult to achieve through ordinary voluntary exercise. In aesthetic and body-contouring settings, HIFEM technology is often used for abdomen, buttocks, arms, thighs or pelvic floor-related applications, depending on the device and clinical indication.

HIFEM is non-invasive and does not require surgery. It is commonly discussed for patients who want to improve muscle tone, body shape and firmness. Some studies also discuss its role in fat reduction and muscle strengthening.

However, HIFEM should not be marketed as a replacement for healthy diet, exercise or medical weight management. It is usually more suitable for body contouring and muscle stimulation than major weight loss.

Patients should inform the physician if they have metal implants, electronic devices, pregnancy, recent surgery, hernia, severe muscle disease or other medical conditions before treatment.

How GlobalMedPool Supports International Patients

For international patients, anti-aging and regenerative medicine in another country can be confusing. The main challenge is not only choosing a treatment, but choosing a safe and appropriate medical pathway.

GlobalMedPool helps patients with:

• Initial needs assessment
• Medical record collection and translation
• Hospital and specialist matching
• Appointment coordination
• Treatment plan communication
• Travel and local support
• Interpretation and patient accompaniment
• Post-treatment follow-up coordination

Our platform can help patients explore anti-aging and regenerative care options at trusted medical institutions in China, including hospitals and medical groups with strong clinical resources such as Shulan Hospital and Ningbo Medical Center Lihuili Hospital.

Who May Be a Suitable Candidate?

Anti-aging and regenerative medicine may be suitable for patients who want to:

• Improve skin quality and facial aging signs
• Explore non-surgical skin tightening
• Support post-procedure recovery
• Improve body contour and muscle tone
• Receive a physician-led wellness assessment
• Combine aesthetic care with broader health management

However, not every patient is suitable for every treatment. The right plan depends on age, medical history, physical condition, skin quality, treatment goals, budget and risk tolerance.

A Responsible Approach to Anti-Aging Medicine

The best anti-aging care is not about chasing every new trend. It is about choosing safe, evidence-informed and personalized options under medical supervision.

Exosome therapy and stem cell-related services require especially careful evaluation because the field is developing quickly and regulations differ across countries. PRP, Thermage FLX and HIFEM may be more familiar in aesthetic medicine, but they still require proper candidate screening and realistic expectations.

Before making a decision, patients should ask for clear information about:

• Treatment purpose
• Medical eligibility
• Expected results
• Possible side effects
• Recovery time
• Number of sessions
• Product or device source
• Doctor qualifications
• Follow-up plan

Start Your Anti-Aging Consultation in China

If you are considering anti-aging or regenerative medicine in China, GlobalMedPool can help you take the first step. Our team will help you organize your medical information, understand available options, connect with suitable medical providers and plan your visit with international patient support.

Contact GlobalMedPool to request a personalized anti-aging and regenerative medicine consultation in China.

Medical Disclaimer: This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment. Exosome therapy, stem cell procedures, PRP, Thermage FLX, HIFEM and other treatments may not be suitable for every patient. Always consult qualified medical professionals before making medical decisions.

 

 

 

 

Ready to explore anti-aging and regenerative medicine options in China?

GlobalMedPool helps international patients connect with trusted hospitals, arrange specialist consultations, translate medical records and coordinate the full medical journey in China.

Request a personalized consultation today.